simurosertib: Clinical Trials

2 trials of simurosertib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow simurosertib: new trials by email Literature Review of simurosertib trials Research Report on simurosertib

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors
TAK-931 PIC, TAK-931 Tablet, Esomeprazole - Neoplasms, Advanced Solid
Phase 1CompletedMillennium Pharmaceuticals, Inc.202019-03-282020-12-29
A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors
TAK-931 - Nonhematologic Neoplasms, Advanced
Phase 1CompletedMillennium Pharmaceuticals, Inc.802016-03-242021-02-21

Conditions studied

Neoplasms (1)

Sponsors

Millennium Pharmaceuticals, Inc. (2)

Countries

Japan (1)  ·  Netherlands (1)

Results publications

PMID 36338546, PMID 36409435, PMID 36970056

NIH funding

2017 (1)